Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jupiter Wellness Inc (NQ: JUPW )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 14, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jupiter Wellness Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
21 Stocks Moving in Thursday's Pre-Market Session
Gainers PainReform Ltd (NASDAQ: PRFX) shares rose 123% to $7.00 in pre-market trading. Second Sight Medical Products Inc (NASDAQ: EYES) shares rose 29% to $5.57 in pre-market... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's... 
Via Benzinga
Jupiter Wellness an Emerging NASDAQ: JUPW: Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis
Via Viz Release
Jupiter Wellness Prices $32.5 Million Underwritten Public Offering of Common Stock and Warrants
JUPITER, FL / ACCESSWIRE / July 21, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the pricing of an underwritten public offering (the "Offering") of 11,066,258 shares... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's morning session saw 27 companies set new 52-week lows. Points of Interest: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed... 
Via Benzinga
Strong Alignments and Sales for Biotech Jupiter Wellness on the NASDAQ: JUPW signs multi-year agreement with Rigour Int. for China, Hong Kong, Korea & S.E. Asian Markets
Via Get News
62 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Exposures Product Safety
Jupiter Wellness Announces Multi-Year Distribution Agreement with Rigour International for Expansion in Asia
JUPITER, FL / ACCESSWIRE / July 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter... 
From Jupiter Wellness, Inc.
Via AccessWire
Strong Alignments and Sales for Biotech Jupiter Wellness on the NASDAQ: JUPW signs multi-year agreement with Rigour Int. for China, Hong Kong, Korea and S.E. Asian Markets
Via Viz Release
Jupiter Wellness Announces Appointment of Dr. Andy Goren to Scientific Advisory Board
JUPITER, FL / ACCESSWIRE / July 15, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that Dr Andy Goren has been appointed to its Scientific Advisory Board. Dr. Andy Goren has more than... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures COVID-19
Biotech Star Jupiter Wellness on the NASDAQ: JUPW Initiates Head-to-Head Trial Comparing JW-100 and Pfizer’s: PFE Eucrisa® for the Treatment of Eczema
Via Get News
Jupiter Wellness Announces initiation of Head-to-Head Trial Comparing JW-100 and Eucrisa(R) for the Treatment of Mild-to-Moderate Eczema
JUPITER, FL / ACCESSWIRE / July 13, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of... 
From Jupiter Wellness, Inc.
Via AccessWire
Biotech Star Jupiter Wellness on the NASDAQ: JUPW Initiates Head-to-Head Trial Comparing JW-100 and Pfizer’s: PFE Eucrisa(R) for the Treatment of Eczema
Via Viz Release
Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis
*Photo-Therapy in a tub JUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced they have entered into an exclusive agreement to license Photocil™, a novel... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Jupiter Wellness an Emerging NASDAQ: JUPW: Licenses Photocil™, a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis & Atopic Dermatitis
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
FDA Filing expected this Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Get News
Exposures Product Safety
FDA Filing expected in Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW)
FDA Filing expected in Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW) 
Via EIN Presswire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
Results of Clinical Study Showing That JW 100 Significantly Reduces ISGA Score in Atopic Dermatitis (AD) Published
https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / ACCESSWIRE / June 22, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
NASDAQ Co Developing Therapeutic & Wellness Products for Skin Disorders, Diseases & Cancers; Jupiter Inc (NASDAQ: JUPW)
NASDAQ Co Quickly Developing Therapeutic & Wellness Products for Skin Disorders, Diseases and Cancers; Jupiter Wellness, Inc. (NASDAQ: JUPW) 
Via EIN Presswire
Topics Intellectual Property Regulatory Compliance
Exposures Intellectual Property Legal Product Safety
Jupiter Wellness Licenses Patents for the Treatment of Contact Dermatitis
JUPITER, FL / ACCESSWIRE / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Jupiter Wellness Enters into Letter of Intent to Acquire JustCBD and its Affiliates
Accretive acquisition would add a profitable company with approximately $28 million of revenue in 2020 (unaudited) JUPITER, FL / ACCESSWIRE / April 20, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products
JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has... 
From Jupiter Wellness, Inc.
Via AccessWire
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Yatsen Holding (NYSE:... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.